Dunad Therapeutics
About:
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Website: https://www.dunad.co.uk
Top Investors: Novartis, BioGeneration Ventures, Epidarex Capital
Description:
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Total Funding Amount:
$24M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2020-01-01
Founders:
Diana Kraskouskaya, Patrick T. Gunning
Number of Employees:
11-50
Last Funding Date:
2021-11-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai